Opioid Receptors and their Ligands
The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
This review gives a historical perspective, summarizing approximately 25 years of research on opioids. The “typical” opioid peptides produced in the brain, “atypical” opioids encrypted in milk protein or hemoglobin sequences, and extremely potent and selective opioids of amphibian origin are described. The main focus is on the structure-activity relationship studies of peptide ligands for three main opioid receptor types (μ, δ, κ), their selectivities and pharmacological activities in vitro. Chemical modifications that led to obtaining potent and selective agonists and antagonists for these receptors are discussed. Keywords: Opioid peptides, opioid agonists and antagonists, structure-activity relationships, opioid receptor selectivity, receptor binding assay
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of two related pentapeptides from the brain with potent opiate agonist activity
Hughes, J., Smith, T. W., Kosterlitz, H. W., Fothergill, L. A., Morgan, B. A., & Morris, H. R. (1975) · Nature · doi:10.1038/258577a0 · Cited by 3,806 · cited 1×
“Three years later the first endogenous opioid peptides, Metand Leu-enkephalins, were isolated and characterized [37].”
BackgroundIsolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor
Meunier, J.-C., Mollereau, C., Toll, L., Suaudeau, C., Moisand, C., Alvinerie, P., Butour, J.-L., Guillemot, J.-C., Ferrara, P., Monsarrat, B., et al. (1995) · Nature · doi:10.1038/377532a0 · Cited by 1,912
A potent and selective endogenous agonist for the µ-opiate receptor
Zadina, J. E., Hackler, L., Ge, L.-J., & Kastin, A. J. (1997) · Nature · doi:10.1038/386499a0 · Cited by 1,311
Cloning of a Delta Opioid Receptor by Functional Expression
Evans, C. J., Keith, D. E., Morrison, H., Magendzo, K., & Edwards, R. H. (1992) · Science · doi:10.1126/science.1335167 · Cited by 1,233
Dynorphin Is a Specific Endogenous Ligand of the κ Opioid Receptor
Chavkin, C., James, I. F., & Goldstein, A. (1982) · Science · doi:10.1126/science.6120570 · Cited by 1,168
ORL1, a novel member of the opioid receptor family: Cloning, functional expression and localization
Mollereau, C., Parmentier, M., Mailleux, P., Butour, J.-L., Moisand, C., Chalon, P., Caput, D., Vassart, G., & Meunier, J.-C. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80235-1 · Cited by 1,077
Kieffer, B. L., Befort, K., Gaveriaux-Ruff, C., & Hirth, C. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12048 · Cited by 1,010
Dynorphin-(1-13), an extraordinarily potent opioid peptide.
Goldstein, A., Tachibana, S., Lowney, L. I., Hunkapiller, M., & Hood, L. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.12.6666 · Cited by 882 · cited 1×
“Systematic truncation of Dyn A at the C-terminus revealed that the shorter Dyn A(1-13) and Dyn A(1-11) and their corresponding analogs with a C-terminal carboxamide function have a in vitro activity profile similar to that of the parent peptide [153-155].”
BackgroundMolecular cloning and functional expression of a mu opioid receptor from rat brain
Chen, Y., Mestek, A., Liu, J., Hurley, A., & Yu, L. (1994) · Regulatory Peptides · doi:10.1016/0167-0115(94)90214-3 · Cited by 810
Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors.
Mosberg, H. I., Hurst, R., Hruby, V. J., Gee, K., Yamamura, H. I., Galligan, J. J., & Burks, T. F. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.19.5871 · Cited by 740
Cited by
Brain-Derived Neurotrophic Factor and Neuropsychiatric Disorders
Autry, A. E., & Monteggia, L. M. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005108 · Cited by 1,390
“Opiates confer these effects by binding to endogenous opioid receptors divided into , , and subtypes, which are highly enriched in the peripheral and central nervous system (Wittert et al., 1996; Janecka et al., 2004).”
BackgroundEEG delta oscillations as a correlate of basic homeostatic and motivational processes
Knyazev, G. G. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.10.002 · Cited by 776
Caseins as source of bioactive peptides
Silva, S. V., & Malcata, F. X. (2005) · International Dairy Journal · doi:10.1016/j.idairyj.2004.04.009 · Cited by 436
Peptides Containing β-Amino Acid Patterns: Challenges and Successes in Medicinal Chemistry
Cabrele, C., Martinek, T. A., Reiser, O., & Berlicki, Ł. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5010896 · Cited by 368
False-Positive Interferences of Common Urine Drug Screen Immunoassays: A Review
Saitman, A., Park, H.-D., & Fitzgerald, R. L. (2014) · Journal of Analytical Toxicology · doi:10.1093/jat/bku075 · Cited by 334
Chai, K. F., Voo, A. Y. H., & Chen, W. N. (2020) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12651 · Cited by 296
Dynorphin activates quorum sensing quinolone signaling in Pseudomonas aeruginosa
Zaborina, O., Lepine, F., Xiao, G., Valuckaite, V., Chen, Y., Li, T., Ciancio, M., Zaborin, A., Petroff, E., Turner, J. R., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030035 · Cited by 207
IL-10 Is Associated with Increased Mu-Opioid Receptor Levels in Major Depressive Disorder
Al-Fadhel, S. Z., Al-Hakeim, H. K., Al-Dujaili, A. H., & Maes, M. (2019) · European Psychiatry · doi:10.1016/j.eurpsy.2018.10.001 · Cited by 44
“β-EP and EM-2 peptides function both as hormones and as neuromodulators [18].”
BackgroundChen, P., Lin, D., Giesler, J., & Li, C. (2011) · Journal of Comparative Neurology · doi:10.1002/cne.22620 · Cited by 39
Metadata
- Authors
- Janecka, A., Fichna, J., & Janecki, T.
- Venue
- Current Topics in Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2004-01-01
- Volume
- 4
- Issue
- 1
- Pages
- 1-17
- ISSN
- 1568-0266 (ISSN-L)
- OpenAlex
- W2104930749
- Cited by
- 311
- References
- 76
- FWCI
- 4.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.